Introduction
Antiviral immune responses are directed not only to components of virus particles, but also to virus-encoded non-structural proteins that appear only in virus-infected cells. For influenza A virus, the non-structural protein NS1 is produced in abundance within infected cells, but is not incorporated into virions (Lamb, 1989; Richardson & Akkina, 1991) . Immune responses to NS1 are of interest, since they are elicited exclusively by active virus infection, and their importance in protective immunity to influenza virus is not yet well understood. Class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTLs) to NSI have been characterized (Bennink et al., 1987; Yewdell et al., 1988; Yewdell & Hackett, 1989 ) and shown to reduce lung virus titres in experimental infections (Kuwano et al., 1990) . Additionally, an L3T4 + T cell clone responsive to influenza virus NS1 has been described, providing evidence that helper T cells may also be directed to NS1 (Kuwano et al., 1990) . To evaluate the potential role of NSl-specific T helper cells in immune responses to influenza virus, we undertook the identification of an t Present address: ImmuLogic Pharmaceutical Corporation, 855 California Avenue, Palo Alto, California 94304, U.S.A. NS1 protein sequence presented by class II MHC and studied recognition of this antigenic region by T cells of virus-infected mice.
Methods
Viruses and viral antigens. Influenza viruses A/Puerto Rico/8/34 (PR8; H1N1), A/USSR/90/77 (HINI), A/Udoru/72 (H3N2), Jl (H3NI) (Bennink et al., 1982) and B/Lee/40 were grown in embryonated hen's eggs and purified where required by sedimentation and banding on sucrose density gradients. Virus concentration in haemagglutinating units (HAU) was determined by chicken erythrocyte agglutination (Fazekas de St Groth & Webster, 1966) . Virus was inactivated by short-wave u.v. light using a UVGLD58 Mineralight lamp (Ultraviolet Products) at 240 p.W/cm 2 for 15 rain. Inactivation was verified by infecting L929 cell monolayers and staining with a monoclonal antibody (MAb) to the NS1 protein (provided by Dr J. W. Yewdell, NIH, Rockville, Md., U.S.A.). Recombinant vaccinia virus expressing the NS1 gene of PR8 influenza virus (NSl-vac) has been described . Vaccinia virus recombinants were grown in BSC cells, harvested and stored frozen at -70 °C as crude virus stocks in Hanks' balanced salt solution containing 0.1 ~ bovine serum albumin (BSA). Isolated influenza PR8 virus NSI protein produced in tives by solid-phase methods and purified by reversed-phase liquid chromatography. Peptide composition was confirmed by amino acid analysis.
Medium. Iscove's modified Dulbecco's medium (IMDM) (Gibco) supplemented with 5% foetal bovine serum was used for in vitro cultures.
Immunizations and T cell hybridomas. Viruses and recombinant products used in the following immunization scheme each derive their NS1 gene from PR8 virus. For intranasal immunization, adult female BALB/c mice were lightly anaesthetized and administered 1 HAU/ mouse infectious allantoic fluid of PR8 virus diluted in 20 Ixl of PBS. To produce hybridomas, adult female BALB/c mice were immunized intraperitoneally, initially with 500 HAU of infectious PR8 virus, boosted 5 weeks later with 500 HAU of infectious influenza reassortant J1 virus (Bennink et al., 1982) , and then 16 weeks later with 1 x 107 p.f.u, of NSl-vac. Splenocytes were taken 12 days after the last inoculation and cultured 3 days in vitro in the presence of recombinant E. coli-derived NS1. These cultures were fused as described (Hurwitz et al., 1984) , using a T cell receptor at-fl-BW5147 parent (White et al., 1989) . Hybridomas secreting lymphokines in response to recombinant E. coli-derived NS1 were cloned by limiting dilution. Class II-MHCrestricted BALB/c T hybridomas specific for influenza virus nucleoprotein (NP) residues 50 to 65 (NP 10-3.1; I-Ad-restricted) and neuraminidase (NA) amino acids 79 to 93 (Hackett et al., 1991 a) (NA 7/11 6.1; I-Ed-restricted) were used as controls, T cell stimulation assays. Hybridomas were tested in cultures containing A20-1.11 B lymphoma antigen-presenting ceils (APC) (5 × 104 to 1 x 105 cells/well), plus antigen dilutions, and T hybridoma cells (2 x 104 to 1 × 105 cells/well). These were cultured in serum-free IMDM containing 0-05% BSA at 37 °C/6% CO2 for 48 to 72 h. To identify the class II MHC restriction of the T cells, antibodies 14-4-4 (Ozato et al., 1980) and MKD6 (Kappler et al., 1981) were included in some experiments at 10 ~tg/ml. Supernatants of T cell cultures were assayed for lymphokine release using the indicator cell lines CTLL-2, HT-2 or DA-1 (Gillis et al., 1978; Palaszynski & Ihle, 1984) . Viability of indicator cells in culture supernatants was quantified by a modification of the original method of Mosmann (1983; Tada et al., 1986; Heeg et al., 1985) using cleavage of the dye 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT). Colour development (absorbance, A) was measured using a Biotek EL309 plate reader at 570 nm.
In vitro T cell responses of intranasally immunized mice to peptides were measured using proliferation assays. Briefly, splenocyte suspensions were cultured (4 x 106/ml) in serum-free IMDM containing 0.5 (v/v) Nutridoma SP (Boehringer Mannheim) for 3 days with dilutions of various antigens. Cultures were then tested for proliferation by uptake of [3H]thymidine. t Results are for those concentrations of antigens which yield maximal IL-2 release in a dose-response curve. Purified E. coli NS1 was used at 25 ~tg/ml. E. coli NSl142-HA2~_2z 2 and E. coli protein control were crude protein preparations of extracts from the same bacterial strain at the same level of purification. These were used in assays at 16 ~tg/ml, ~/NO, Not done. Table 3 ). The hybridoma was found to be restricted to the class II I-E d molecule; the I-E dspecific MAb 14-4-4, and not the I-Ad-binding MKD6, inhibited antigen recognition (data not shown). Definitive data showing that viral NS1 was recognized relied upon recombinant E. coli proteins. Hybrid 27-2, and not a T hybridoma specific for NA, responded to full-length PR8 virus NS1 in the absence of other influenza proteins (Table 2) . No responses were seen Table 3 . Localization of the T cell epitope to residues 13 to 32 of NS1 by differential recognition of H1 and H3 viruses and synthetic peptides Amino acid sequence of residues 1 to 42 of influenza virus NS1 proteins (data from Krystal et al., 1983 t Infectious allantoic fluid was used at 240 HAU/ml dilution to pulse APC, which were washed and serially diluted for T cell stimulation cultures.
Results and Discussion
:~ A/Udorn/72 (H3N2) virus was not recognized by the Nl-specific T hybridoma NA 7/11 (above) but was recognized by the subtype cross-reactive T hybridoma NP 10-3.1 (specific for residues 50 to 69 of NP), giving a net A57 o of 1.053 in the presence of 0.5 HAU/ml of PR8 virus allantoic fluid.
§ Peptides were used at concentrations of 4 gg/ml or, for NS 1 13-32, at 8 ~tg/ml when cocultured with peptide NS1 1-15. PR8 virus allantoic fluid was used at 3 HAU/ml. with partially purified E. coli protein controls. However, hybrid E. coli proteins NSll.81-HA21.222 (data not shown) and NS1142-HA21_222 (Table 2) , known to elicit or restimulate class I MHC-restricted CTLs in BALB/c mice (Yamada et al., 1985; S. B. Dillon et al., unpublished observations) , were recognized by clone 27-2. The relevant epitope therefore resides within the first 42 amino acids of NS1.
Studies with heterosubtypic virus and synthetic peptides localized the T cell epitope to a short segment of NS1 differing in sequence between H1 and H3 influenza viruses. Table 3 shows that hybridoma 27-2 T cells did not recognize subtype H3 A/Udorn virus, but responded to the related H1 strain A/USSR/90/77. Amino acid changes between HI and H3 NS1 molecules in the first 42 amino acids are known at positions 3 and 23 (Buonagurio et al., 1986) . Accordingly, peptides encompassing residues 1 to 15 and 13 to 32 were synthesized. Table 3 shows that only the 13 to 32 amino acid segment was recognized by 27-2, and did not stimulate a NAspecific T hybridoma. Truncated peptides are needed to delineate further the minimally sized determinant within this region, and peptide analogues bearing the A/Udorn/72 substitution of valine for alanine at position 23 are required to verify the effect of that alteration on T cell recognition. It should be noted that the T cell epitope defined here appears to be different from that discussed by Kuwano et al. (1990) , which cross-reacted with H3 strains, and whose location was known only to be within the first 81 amino acids of NS1. This region is also distinct from that recognized by a class I MHC-restricted NSl-specific CTL clone (residues 50 to 68) (Kuwano et al., 1991) .
We could then ask whether the NS1 13 to 32 region is a significant target in mice infected with influenza virus. BALB/c mice were primed intranasally with PR8 virus, and 9 to 15 days later draining lymph node and spleen cells were tested in vitro for recognition of peptide in proliferation assays. Table 4 shows that a single immunization with live virus induced proliferating cells responding to peptide NS1 13-32. These proliferating cells released interleukin 3 (data not shown), confirming that T cells were being stimulated. Non-immunized mice did not respond to NS1 13-32 nor to other known antigenic influenza virus peptides. The T cell response to NS1 13-32 compared favourably in magnitude with that seen to NA 79-93 and HA 111-129 (Table 4) , which are known to be major I-Ed-restricted T cell epitopes of PR8 virusNA and HA (Hackett et al., 1991a; Gerhard et al., 1991) . Although quantitative data would be required to establish rigorously the frequency of NS1 13-32-specific T cells in virus-immunized mice, these data suggest that we have identified an epitope of NS1 which serves as a significant target antigen for class II MHC-restricted T ceils responding to virus infection. T cell responses to non-structural proteins of several other viruses have frequently been found to be class I MHC-restricted (Bukowski et al., 1989; Del Valet al., 1988; Borysiewicz et al., 1988; Martin et aL, 1988; Koenig et aL, 1990) ; however, class II MHC-restricted T cells to nonstructural proteins have been found in responses to such diverse viruses as dengue (Kurane et al., 1991) and human immunodeficiency virus type 1 (Bahraoui et al., 1990) , as well as to influenza virus. Therefore, helper T cells to non-structural proteins may be a common feature of immune responses to many viruses.
The NS1 13-32 T cell epitope can be presented by MHC class II molecules when provided either as an endogenously synthesized antigen or as an exogenous protein. Current information suggests that different antigen-processing pathways may be utilized in antigen presentation depending upon whether antigen is acquired in endosomes or biosynthesized in the cytosol of APCs (Germain, 1986; Long, 1989; Jaraquemada et al., 1990; Nuchtern et al., 1990; Thomas et al., 1990; Hackett et al., 1991 b) . The ability of NS 1 to be presented in context of both class I and class II MHC in influenza virus-infected cells, as well as from exogenously added recombinant E. coli proteins, should be useful in analysing various antigen-processing routes that the molecule may encounter. Additionally, these observations suggest that cells should also be able to present foreign genes packaged and expressed under the control of NSI genetic elements in recombinant influenza virus (Luytjes et al., 1989) , which could be employed to study antigen presentation of various viral and non-viral proteins biosynthesized, as NS1, within virus-infected APCs.
Availability of an NS1 helper T cell epitopic peptide should enable further studies of the role of NS1 in immunity to influenza. These include quantitative estimates of the precursor frequency and genetic diversity of NSl-specific T cells, and the effect on protective immunity of intentionally priming NSl-specific helper T cells. Significant for vaccine design, this study identifies a class II MHC-restricted T cell determinant which could not be elicited by immunization with inactivated virus or by virion subunit vaccines, indicating that live virus or constructs including at least portions of NS1 may be needed to elicit the full repertoire of T helper cells that function in an influenza virus challenge.
